MENOPAUSAL TRANSITION AND MENOPAUSAL SYNDROME IN WOMEN AFTER THE COVID-19

Азамкулова Нозима Одилжоновна, Иргашева Севара Уткуровна

Journal of reproductive health and uro-nephrology research (Репродуктив саломатлик ва уро-нефрологик тадқиқотлар журнали) · 2023-yil

Annotatsiya

In the last decade, the concept of "active longevity" has been actively promoted, where a special place is occupied by the age aspects of women's health. The perimenopausal period of women's life is due to the consequences of estrogen deficiency, which in turn leads to physiological changes and diseases of other systems. The protection of menopausal hormone therapy improves the background state of the immune system and the coagulation system, increasing additional mechanisms for protecting the vascular wall. However, in the context of the ongoing COVID-19, many open questions arise regarding the prescription of menopausal hormone therapy, primarily the degree of their effectiveness and safety in SARS CoV-2. The answers to these questions are ambiguous due to the insufficient scientific evidence base and remain relevant.

Maqola ma’lumotlari
MualliflarАзамкулова Нозима Одилжоновна, Иргашева Севара Уткуровна
JurnalJournal of reproductive health and uro-nephrology research (Репродуктив саломатлик ва уро-нефрологик тадқиқотлар журнали)
Nashr sanasi2023-09-21
Jild4
Son3
TilRus

Kalit so‘zlar

COVID-19, перименопауза, женское здоровье , менопаузальная гормональная терапия, фитоэстрогены, COVID-19, Perimenopausal period, Women's health, Menopausal hormone therapy, Phytoestrogens, COVID-19, Perimenopauza davri, Ayol sog’ligi, Menopauzal gormonal terapiya, Fitoestrogenlar

Ilmiy soha

Journal of reproductive health and uro-nephrology research (Репродуктив саломатлик ва уро-нефрологик тадқиқотлар журнали) jurnalidan boshqa maqolalar

Journal of reproductive health and uro-nephrology research (Репродуктив саломатлик ва уро-нефрологик тадқиқотлар журнали) — barcha maqolalar